AstraZeneca, Oxford University say COVID-19 vaccine shows 70% efficacy
British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against COVID-19 has shown “an average efficacy of 70 percent” in trials. “This vaccine’s efficacy…
COVID-19: Pfizer-BioNTech vaccine deliveries could begin Dec.
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no…
Made in india COVID-19 vaccine could be launched as early as February – government scientist
An Indian government-backed COVID-19 vaccine could be launched as early as February – months earlier than expected – as last-stage trials begin this month and studies have so far showed…
COVID-19: Vaccine Alliance says poorer nations to get 100m extra vaccine doses by 2021
Up to 100 million additional doses of any eventual COVID-19 vaccines will be secured for delivery to poorer countries in 2021, Gavi, the Vaccine Alliance, announced Tuesday. The announcement doubles…
AstraZeneca COVID-19 vaccine trials resume in Brazil
Clinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country’s health regulator got confirmation over the weekend that…
Vaccine trials: Temporary suspensions ‘not unusual’ – WHO
Safety is paramount in vaccine clinical trials and temporary suspensions are not unusual to evaluate any unexplained illness in a participant, the World Health Organization (WHO) said on Wednesday regarding…
Britain’s medical regulator says urgently reviewing AstraZeneca COVID-19 vaccine trial data
Britain’s medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca can restart trials of its experimental coronavirus vaccine after an unexplained illness in a…
COVID-19: WHO says vaccine safety top priority, as AstraZeneca pauses study
Safety of a prospective vaccine for COVID-19 comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused,…
US States told to be ready to distribute COVID-19 vaccine Nov 1
The Trump administration has urged US states to get ready to distribute a potential COVID-19 vaccine by November 1 — two days before the presidential election. Dallas-based wholesaler McKesson Corp….
Scientists see problems with top COVID-19 vaccines from Russia, China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their…